Skip to main content
NMR
NYSE Finance

Nomura Holdings Reports Significant ROE Improvement and Robust Governance Framework

Analysis by Wiseek.ai
Sentiment info
Positive
Importance info
8
Price
$9.34
Mkt Cap
$26.751B
52W Low
$4.86
52W High
$9.47
Market data snapshot near publication time

summarizeSummary

Nomura Holdings updated its corporate governance report, highlighting significant improvements in Return on Equity (ROE) to 10.0% for FY2025 and 11.3% for H1 FY2026, alongside a PBR of 1.1x, demonstrating strong progress towards its 2030 financial targets.


check_boxKey Events

  • Strong ROE Performance Exceeds Targets

    The company reported a significant improvement in Return on Equity (ROE), reaching 10.0% for the fiscal year ended March 2025 and further increasing to 11.3% for the first half of the fiscal year ended March 2026. This performance surpasses the company's estimated cost of equity of 8% and aligns with its 2030 target of 8-10% or higher.

  • Improved Price-to-Book Ratio

    Nomura Holdings' Price-to-Book Ratio (PBR) improved to 1.1 times as of December 31, 2025, indicating enhanced market valuation relative to its book value.

  • Robust Corporate Governance Framework

    The report details a comprehensive corporate governance system, including full compliance with the Corporate Governance Code, a Board of Directors with a majority of independent members (8 out of 12), and the operation of three statutory committees (Nomination, Audit, Compensation) to ensure strong oversight and transparency.

  • Commitment to Diversity and Sustainability

    Nomura Holdings outlined its initiatives to promote diversity, equity, and inclusion (DEI), including quantitative targets for female managers and a high ratio of mid-career and overseas managers. The company also detailed its sustainability efforts, including net-zero GHG emissions targets and human rights policies.


auto_awesomeAnalysis

Nomura Holdings' latest corporate governance report highlights substantial progress in key financial metrics, with Return on Equity (ROE) reaching 10.0% for FY2025 and further improving to 11.3% for the first half of FY2026. This performance exceeds the company's stated cost of equity of approximately 8% and aligns with its 2030 target of 8-10% or higher, demonstrating effective management and value creation. The report also notes an improved Price-to-Book Ratio (PBR) of 1.1 times as of December 31, 2025. This positive financial update, coupled with a comprehensive and transparent governance structure featuring a majority of independent and diverse directors, reinforces investor confidence, especially as the company's stock trades near its 52-week high.

At the time of this filing, NMR was trading at $9.34 on NYSE in the Finance sector, with a market capitalization of approximately $26.8B. The 52-week trading range was $4.86 to $9.47. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed NMR - Latest Insights

NMR
Apr 28, 2026, 6:01 AM EDT
Filing Type: 6-K
Importance Score:
7
NMR
Apr 24, 2026, 7:41 AM EDT
Filing Type: 6-K
Importance Score:
8
NMR
Apr 24, 2026, 6:09 AM EDT
Filing Type: 6-K
Importance Score:
8
NMR
Apr 15, 2026, 7:34 AM EDT
Filing Type: 6-K
Importance Score:
8
NMR
Apr 14, 2026, 6:01 AM EDT
Filing Type: 6-K
Importance Score:
8
NMR
Apr 01, 2026, 6:01 AM EDT
Filing Type: 6-K
Importance Score:
7
NMR
Mar 02, 2026, 6:01 AM EST
Filing Type: 6-K
Importance Score:
7
NMR
Feb 06, 2026, 6:01 AM EST
Filing Type: 6-K
Importance Score:
8
NMR
Jan 30, 2026, 6:03 AM EST
Filing Type: 6-K
Importance Score:
9
NMR
Jan 30, 2026, 6:02 AM EST
Filing Type: 6-K
Importance Score:
7